Therapeutic strategy targeting the mTOR-HIF-1α-VEGF pathway in ovarian clear cell adenocarcinoma

MIYAZAWA Masaki; YASUDA Masanori; FUJITA Mariko; KAJIWARA Hiroshi; HIRABAYASHI Kenichi; TAKEKOSHI Susumu; HIRASAWA Takeshi; MURAKAMI Masaru; OGANE Naoki; KIGUCHI Kazushige; ISHIWATA Isamu; MIKAMI Mikio; OSAMURA R. Yoshiyuki

Art

J-GLOBAL ID：200902260664192261 Reference number：09A0111369

Therapeutic strategy targeting the mTOR-HIF-1α-VEGF pathway in ovarian clear cell adenocarcinoma

卵巣の明細胞腺癌においてmTOR-HIF-1α-VEGF経路を標的化する治療方針

Publisher site {{ this.onShowPLink() }} Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=09A0111369&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=09A0111369&from=J-GLOBAL&jstjournalNo=W0853A") }}

Author (13)： , , , , , , , , , , , ,
Material：
Volume： 59 Issue： 1 Page： 19-27 Publication year： Jan. 2009
JST Material Number： W0853A ISSN： 1320-5463 Document type： Article
Article type：原著論文 Country of issue： Australia (AUS) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=09A0111369&from=J-GLOBAL&jstjournalNo=W0853A") }}

Tumors(=neoplasms)of female genitalia and fetus , Basic research of antitumor(=antineoplastic)drugs

Reference (41)：

PALEY, PJ. Ovarian cancer screening : Are we making any progress?. Curr Opin Oncol. 2001, 13, 399-402
SHINOZUKA, T. High dose chemotherapy with autologous stem cell support in the treatment of patients with ovarian carcinoma : Long term results for 105 patients. Cancer. 1999, 85, 1555-1564
OZOLS, RF. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer : A Gynecologic Oncology Group study. J Clin Oncol. 2003, 21, 3194-3200
SUGIYAMA, T. Clinical characteristics of clear cell carcinoma of the ovary : A distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer. 2000, 88, 2584-2589
ITAMOCHI, H. Low proliferation activity may be associated with chemoresistance in clear cell carcinoma of the ovary. Obstet Gynecol. 2002, 100, 281-287

ｍore...

, , , ,

Return to Previous Page